Last week's close (Rs)
1,653.08
Prev. week's close (Rs)
1,606.65
Week's high (Rs)
1,661.48
Week's low (Rs)
1,598.00
Last week's ave. daily turnover (Rs cr)
174.54
Prev. week's ave. daily turnover (Rs cr)
175.98
Futures close September-2004 (Rs)
1,649.10
Futures close October-2004 (Rs)
1,654.35
Futures close November-2004 (Rs)
0.00
Number of up/down move
4/1
Infosys touched a new high of Rs 1,645 on Friday, and finally ended with a 2.9-per cent gain over its previous weekly close. This is the highest level the scrip achieved in three-and-a-half years since February 2001.
| HLL | |
| Last week's close (Rs) | 121.00 |
| Prev. week's close (Rs) | 110.80 |
| Week's high (Rs) | 121.75 |
| Week's low (Rs) | 110.43 |
| Last week's ave. daily turnover (Rs cr) | 55.19 |
| Prev. week's ave. daily turnover (Rs cr) | 18.18 |
| Futures close September-2004 (Rs) | 121.30 |
| Futures close October-2004 (Rs) | 121.95 |
| Futures close November-2004 (Rs) | 0.00 |
| Number of up/down move | 5/0 |
HLL benefited from a massive bout of bargain hunting to finally end the week with a handsome 9.2 per cent gain over its previous weekly close. The counter witnessed volumes of over 18.25 lakh shares on the BSE on Thursday.
| RANBAXY | |
| Last week's close (Rs) | 1024.77 |
| Prev. week's close (Rs) | 977.00 |
| Week's high (Rs) | 1028.95 |
| Week's low (Rs) | 972.65 |
| Last week's ave. daily turnover (Rs cr) | 42.56 |
| Prev. week's ave. daily turnover (Rs cr) | 25.99 |
| Futures close September-2004 (Rs) | 1020.10 |
| Futures close October-2004 (Rs) | 1020.00 |
| Futures close November-2004 (Rs) | 1023.00 |
| Number of up/down move | 3/2 |
Ranbaxy advanced 4.89 per cent last week to close at Rs 1024.77. It received a tentative approval from the US Food and Drug Administration (USFDA) to manufacture and market Levofloxacin tablets, 250 mg, 500 mg, and 750 mg.
| CIPLA | |
| Last week's close (Rs) | 260.68 |
| Prev. week's close (Rs) | 235.13 |
| Week's high (Rs) | 262.85 |
| Week's low (Rs) | 231.68 |
| Last week's ave. daily turnover (Rs cr) | 25.10 |
| Prev. week's ave. daily turnover (Rs cr) | 8.23 |
| Futures close September-2004 (Rs) | 261.00 |
| Futures close October-2004 (Rs) | 253.05 |
| Futures close November-2004 (Rs) | 0.00 |
| Number of up/down move | 3/2 |
Cipla had a great outing last week. It zoomed over 10.8 per cent over its previous weekly close. The buying interest at the counter was ignited by robust August sales.
| | ||||||||||||||||||
| ||||||||||||||||||
| The markets gave a thumbs down to Zee Telefilms last week ahead of a Bombay High Court's order which required Zee and ESPN-Star Sports to make fresh bids for the telecast rights of cricket matches to be played in India. | ||||||||||||||||||
| The stock tumbled almost 6 per cent with heavy selling at the bourses. The Zee board is to meet today (September 13) to decide whether to opt for fresh bids. Only if Zee decides to make fresh bids will the petition filed by ESPN-Star Sports stand withdrawn. | ||||||||||||||||||
| The markets do not seem very pleased with the whole exercise even though the deal will rake in some moolah for Zee. If Zee manages the whole show in its favour again, then the stock will need some positive attention.
| ||||||||||||||||||
| | ||||||||||||||||||
| ||||||||||||||||||
| ITC ended last week with gains - the scrip registered an increase of 6.4 per cent amidst a whopping 276 per cent ascent in turnover. However, the stock remained volatile, moving almost 90 price points. | ||||||||||||||||||
| The buying interest was triggered by a court order which freed ITC of Rs 803 crore of excise burden. The markets cheered the stock which turned out to be the biggest gainer on Thursday. | ||||||||||||||||||
| Though the court held back the order briefly, the 17-year old legal battle finally ended on Friday, bringing relief to the company. Now markets wait for Rs 803 crore to flow into ITC's profits (the amount is now maintained as provisions).
|
| | ||||||||||||||||||
| ||||||||||||||||||
| Subex Systems was among the gainers last week, moving up 5.48 per cent to close at Rs 329.65. The upsides followed reports that Intel Capital Corp, the investment arm of US-based Intel Corp, may increase its stake in the Bangalore-based company by converting 479,500 preference shares into equity shares in the ratio of 1:1. | ||||||||||||||||||
| The board of Subex will meet this week to consider the conversion. Intel Capital holds a 10 per cent stake in Subex. Subex shares have gained more than 30 per cent since the end of June. | ||||||||||||||||||
| In July its board approved raising the FII investment limit up to 74 per cent of the company's paid up equity capital. The company had recently bought Alcatel's fraud management unit for $3 million. It will get 30 new clients from the acquisition.
| ||||||||||||||||||
| | ||||||||||||||||||
| ||||||||||||||||||
| AFT Industries had a great outing last week in the course of which it zoomed over 34 per cent from its previous weekly close. Dealers attribute the rush of buying at the counter to the rise in tea prices, which benefited the company's operating income in the last quarter. | ||||||||||||||||||
| According to a leading broking firm, "mid-cap stocks have been performing well. So mid-cap tea companies are also attracting market attention." | ||||||||||||||||||
| Prices at tea auctions have shown an upward trend and this is likely to continue in the remaining part of the year as well.
| ||||||||||||||||||